| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* Lymphocyte Biology Section, Division of Rheumatology, Immunology, and Allergy, Department of Medicine, and
Department of Pathology, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA 02115
Citrobacter rodentium uses virulence factors similar to the enteropathogenic Escherichia coli to produce attaching and effacing lesions in the distal colon of mice. We used this infection model to determine components of adaptive immunity needed to survive infection. During acute infection, wild-type mice develop breaks across infected epithelial surfaces but resolve infection. Surprisingly, mice markedly deficient in mucosal lymphocyte populations from 
7 integrin deficiency resolve infection, as do CD8
-/- or TCR-
-/- mice. In contrast, CD4-/- or TCR--/- mice develop polymicrobial sepsis and end-organ damage, and succumb during acute infection, despite epithelial damage similar to wild-type mice. B cell-deficient (MuMT-/-) or B and T cell-deficient (recombinase-activating gene 2-/-) mice develop severe pathology in colon and internal organs, and deteriorate rapidly during acute infection. Surviving mice develop robust Citrobacter-specific serum IgM responses during acute infection, whereas mice that succumb do not. However, CD4-/- mice receiving serum Igs from infected wild-type mice survive and clear the infection. Our data show that survival of apparently self-limited and luminal mucosal infections requires a systemic T cell-dependent Ab response against bacteria that enter through damaged mucosa. These findings have implications for understanding host defense against mucosal infections, including the pathogenesis of these diseases in immunocompromised populations.
This article has been cited by other articles:
|
|
 |
|
  N. Jandu, Z. J. Zeng, K. C. Johnson-Henry, and P. M. Sherman Probiotics prevent enterohaemorrhagic Escherichia coli O157 : H7-mediated inhibition of interferon-{gamma}-induced tyrosine phosphorylation of STAT-1 Microbiology, February 1, 2009; 155(2): 531 - 540. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Dennis, T. Kudo, L. Kruidenier, F. Girard, V. F. Crepin, T. T. MacDonald, G. Frankel, and S. Wiles The p50 Subunit of NF-{kappa}B Is Critical for In Vivo Clearance of the Noninvasive Enteric Pathogen Citrobacter rodentium Infect. Immun., November 1, 2008; 76(11): 4978 - 4988. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Harrington, C. V. Srikanth, R. Antony, S. J. Rhee, A. L. Mellor, H. N. Shi, and B. J. Cherayil Deficiency of Indoleamine 2,3-Dioxygenase Enhances Commensal-Induced Antibody Responses and Protects against Citrobacter rodentium-Induced Colitis Infect. Immun., July 1, 2008; 76(7): 3045 - 3053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. Dann, M. E. Spehlmann, D. C. Hammond, M. Iimura, K. Hase, L. J. Choi, E. Hanson, and L. Eckmann IL-6-Dependent Mucosal Protection Prevents Establishment of a Microbial Niche for Attaching/Effacing Lesion-Forming Enteric Bacterial Pathogens J. Immunol., May 15, 2008; 180(10): 6816 - 6826. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Masuda, M. Yoshida, H. Shiomi, S. Ikezawa, T. Takagawa, H. Tanaka, R. Chinzei, T. Ishida, Y. Morita, H. Kutsumi, et al. Fc{gamma} Receptor Regulation of Citrobacter rodentium Infection Infect. Immun., April 1, 2008; 76(4): 1728 - 1737. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Borenshtein, P. R. Nambiar, E. B. Groff, J. G. Fox, and D. B. Schauer Development of Fatal Colitis in FVB Mice Infected with Citrobacter rodentium Infect. Immun., July 1, 2007; 75(7): 3271 - 3281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Lebeis, B. Bommarius, C. A. Parkos, M. A. Sherman, and D. Kalman TLR Signaling Mediated by MyD88 Is Required for a Protective Innate Immune Response by Neutrophils to Citrobacter rodentium J. Immunol., July 1, 2007; 179(1): 566 - 577. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Khan, C. Ma, L. A. Knodler, Y. Valdez, C. M. Rosenberger, W. Deng, B. B. Finlay, and B. A. Vallance Toll-Like Receptor 4 Contributes to Colitis Development but Not to Host Defense during Citrobacter rodentium Infection in Mice. Infect. Immun., May 1, 2006; 74(5): 2522 - 2536. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Bry, M. Brigl, and M. B. Brenner CD4+-T-Cell Effector Functions and Costimulatory Requirements Essential for Surviving Mucosal Infection with Citrobacter rodentium Infect. Immun., January 1, 2006; 74(1): 673 - 681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-C. Chen, S. Louie, B. McCormick, W. A. Walker, and H. N. Shi Concurrent Infection with an Intestinal Helminth Parasite Impairs Host Resistance to Enteric Citrobacter rodentium and Enhances Citrobacter-Induced Colitis in Mice Infect. Immun., September 1, 2005; 73(9): 5468 - 5481. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. L. Wei, A. Hilliard, D. Kalman, and M. Sherman Mast Cells Limit Systemic Bacterial Dissemination but Not Colitis in Response to Citrobacter rodentium Infect. Immun., April 1, 2005; 73(4): 1978 - 1985. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. K. F. Li, S. L. F. Pender, K. M. Pickard, V. Chance, J. A. Holloway, A. Huett, N. S. Goncalves, J. S. Mudgett, G. Dougan, G. Frankel, et al. Impaired Immunity to Intestinal Bacterial Infection in Stromelysin-1 (Matrix Metalloproteinase-3)-Deficient Mice J. Immunol., October 15, 2004; 173(8): 5171 - 5179. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
